Bristol-Myers Squibb Position Trimmed by John G Ullman Associates Inc.
| SUHIX Fund | USD 46.27 0.22 0.48% |
Slightly above 53% of Deutsche Health's investor base is interested to short. The analysis of overall sentiment of trading Deutsche Health And mutual fund suggests that many investors are impartial at this time. Deutsche Health's investing sentiment can be driven by a variety of factors including economic data, Deutsche Health's earnings reports, geopolitical events, and overall market trends.
Deutsche |
John G Ullman Associates Inc. lowered its stake in shares of Bristol-Myers Squibb by 30.5 percent in the third quarter, according to its most recent filing with the Securities and Exchange Commission . The firm owned 158,350 shares of the biopharmaceutical companys stock after selling 69,465 shares during the quarter. Bristol-Myers
Read at thelincolnianonline.com
 |
Deutsche Health Fundamental Analysis
We analyze Deutsche Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Deutsche Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Deutsche Health based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
Deutsche Health is currently under evaluation in price to sales among similar funds. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Deutsche Health And Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Deutsche Health mutual fund to make a market-neutral strategy. Peer analysis of Deutsche Health could also be used in its relative valuation, which is a method of valuing Deutsche Health by comparing valuation metrics with similar companies.
Peers
Deutsche Health Related Equities
| IBRIX | Vy(r) Blackrock | 0.43 | ||||
| ABNYX | Ab Bond | 0.29 | ||||
| ABNOX | Ab Bond | 0.29 | ||||
| HIPCX | The Hartford | 0.10 | ||||
| QMHRX | Aqr Managed | 0.46 | ||||
| QMHIX | Aqr Managed | 0.46 |
Other Information on Investing in Deutsche Mutual Fund
Deutsche Health financial ratios help investors to determine whether Deutsche Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Deutsche with respect to the benefits of owning Deutsche Health security.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |